Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-025244

Chief Financial Officer sold 1,477 shares at $2.88 ($4,257)

From the SEC's structured data for this filing

Trades in this filing

Ondrey Aaron · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-07-03 Sale : show line 1 in the form −1,477 $2.88 $4,257 128,173 D
Open-market sales · 1,477 sh · avg $2.88 · $4,257
Loading xslF345X05/form4.xml…